These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Specificity of hemagglutination-inhibition with adenovirus particles of subgroup I and III. Wigand R; Keller D Arch Gesamte Virusforsch; 1974; 46(3-4):381-4. PubMed ID: 4476202 [No Abstract] [Full Text] [Related]
46. The effect of arginine deprivation on the replication of vaccinia virus. Archard LC; Williamson JD J Gen Virol; 1971 Sep; 12(3):249-58. PubMed ID: 4256170 [No Abstract] [Full Text] [Related]
48. Two haemagglutinating components of vesicular stomatitis virus. Arstila P Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(1):33-40. PubMed ID: 4336304 [No Abstract] [Full Text] [Related]
49. Separation and purification of the biological active viral components, hemagglutinin and nucleoprotein-neuraminidase from some influenza A2 strains. Alexandrescu M; Handrache L; Moroşanu V; Vancea G; Ionescu L; Colev A; Duda R; Duca M Rev Roum Inframicrobiol; 1971; 8(2):43-8. PubMed ID: 5164576 [No Abstract] [Full Text] [Related]
50. Two components specifically responsible for hemagglutination in vaccinia and cowpox viruses. Ikuta K; Miyamoto H; Kato S Virology; 1979 Jul; 96(1):327-31. PubMed ID: 88801 [No Abstract] [Full Text] [Related]
51. The occurrence of Ag determinants in different lipoproteins. Ehnholm C; Bütler R; Brunner E Vox Sang; 1973 Sep; 25(3):281-5. PubMed ID: 4126733 [No Abstract] [Full Text] [Related]
52. Early virus protein synthesis in vaccinia virus-infected cells. Esteban M; Metz DH J Gen Virol; 1973 May; 19(2):201-6. PubMed ID: 4268458 [No Abstract] [Full Text] [Related]
53. The polypeptides of influenza virus. 8. Large-scale purification of the hemagglutinin. Stanley P; Crook NE; Streader LG; Davidson BE Virology; 1973 Dec; 56(2):640-5. PubMed ID: 4796551 [No Abstract] [Full Text] [Related]
54. The production of vaccinia haemagglutinin by the chorioallantoic membrane of embryonated eggs. METCALF D Aust J Exp Biol Med Sci; 1955 Feb; 33(1):45-52. PubMed ID: 14389173 [No Abstract] [Full Text] [Related]
55. Method for the purification and concentration of Vaccinia-virus. Orlov G; Gancheva T; Kavaklova L; Vacheva V Zentralbl Bakteriol Orig A; 1972 Nov; 222(2):174-9. PubMed ID: 4144792 [No Abstract] [Full Text] [Related]
56. Separation and characterization of products of two measles virus variants. Chiarini A; Norrby E Arch Gesamte Virusforsch; 1970; 29(2):205-14. PubMed ID: 4986498 [No Abstract] [Full Text] [Related]
57. [Isolation of surface antigens of influenza virus A/Hong Kong 1/68 (H3N2) by density gradient fractionation with a new carboxypolypeptidase (author's transl)]. Bottex C; Chatot G; Fontanges R Arch Virol; 1975; 48(1):9-19. PubMed ID: 238492 [TBL] [Abstract][Full Text] [Related]
58. Polyacrylamide gel electrophoresis of fowlpox and vaccinia virus proteins. Obijeski JF; Palmer EL; Gafford LG; Randall CC Virology; 1973 Feb; 51(2):512-6. PubMed ID: 4348307 [No Abstract] [Full Text] [Related]
59. Envelope protein of influenza virus. II. Antigenicity. Eckert EA Arch Environ Health; 1970 Sep; 21(3):316-20. PubMed ID: 5504433 [No Abstract] [Full Text] [Related]
60. Differentiation of ectromelia virus haemagglutinin from haemagglutinins of other poxviruses. Mills T; Pratt BC Arch Virol; 1980; 63(2):153-7. PubMed ID: 7356392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]